• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

BTI's Magnes II cleared in Japan

Article

Magnetic source imaging developer Biomagnetic Technologies ofSan Diego announced last month that its Japanese distributor,Sumitomo Metal Industries, has received clearance from the JapaneseMinistry of Health to market its Magnes II MSI system. The

Magnetic source imaging developer Biomagnetic Technologies ofSan Diego announced last month that its Japanese distributor,Sumitomo Metal Industries, has received clearance from the JapaneseMinistry of Health to market its Magnes II MSI system. The actionmeans that Magnes II can be marketed in other Asian countriesthat recognize the Japanese agency's approval.

On the downside, BTI last month posted lower financial numbersfor its third quarter (end-June). Revenues for the quarter were$1.8 million, down 27% compared to $2.5 million in the same periodin 1994. The firm's net loss was $2.2 million, which includeda non-recurring charge of $595,000, compared to a net loss of$1.4 million in the third quarter of 1994.

The company's backlog is at $11.3 million, however, which isthe highest level in BTI's history. It was aided by an order inAugust for a Magnes Whole Head system, a next-generation MSI scannerintroduced at last year's Radiological Society of North Americameeting (SCAN 3/15/95). That system will be shipped to the Institutefor Research in Neurosciences and Psychiatry in Rouffach, France.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.